About

Initial development is focused on highly efficacious, universal vaccines that prevent significant current and new infectious diseases in animals with translational opportunities in humans.

MBFT has assembled an extensive technology platform including multiple check point inhibitors, immunomodulators, adjuvants and delivery systems that work in concert to modulate the immune system, stimulating a durable cell mediated effector and memory response against a broad range of pathogens and cancers.